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Background: A global map of protein-protein interactions in cellular systems provides key insights into the
workings of an organism. A repository of well-validated high-quality protein-protein interactions can be used in
both large- and small-scale studies to generate and validate a wide range of functional hypotheses.
Results: We develop HINT (http://hint.yulab.org) - a database of high-quality protein-protein interactomes for
human, Saccharomyces cerevisiae, Schizosaccharomyces pombe, and Oryza sativa. These were collected from several
databases and filtered both systematically and manually to remove low-quality/erroneous interactions. The
resulting datasets are classified by type (binary physical interactions vs. co-complex associations) and data source
(high-throughput systematic setups vs. literature-curated small-scale experiments). We find strong sociological
sampling biases in literature-curated datasets of small-scale interactions. An interactome without such sampling
biases was used to understand network properties of human disease-genes - hubs are unlikely to cause disease,
but if they do, they usually cause multiple disorders.
Conclusions: HINT is of significant interest to researchers in all fields of biology as it addresses the ubiquitous need
of having a repository of high-quality protein-protein interactions. These datasets can be utilized to generate
specific hypotheses about specific proteins and/or pathways, as well as analyzing global properties of cellular
networks. HINT will be regularly updated and all versions will be tracked.
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Numerous recent efforts in systems biology have tried to
characterize the set of all possible pairwise physical
interactions or the binary protein “interactome” of an or-
ganism [1-3]. Most proteins perform their functions
through interactions [4]. Thus, these large-scale maps
are critical in elucidating the biological roles of func-
tional products of genes that are identified by large-scale
genome and cDNA sequencing projects. Because most
of these efforts are discovery-oriented and try to explore
previously unknown functionalities, it is of utmost im-
portance to ensure that the resultant maps are of high
quality. Erroneous results at this stage could propagate
into both ill-conceived hypotheses and futile down-
stream experiments. Moreover, it has been shown that* Correspondence: haiyuan.yu@cornell.edu
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reproduction in any medium, provided the orhigh-quality interaction networks can provide key
insights into fundamental topological and biological
properties of cellular systems [5-8]. Although there are
numerous databases [9-16] that try to systematically cur-
ate the entire repository of interactions for different
organisms, there has been very little effort in filtering
out unreliable ones. This has led to low overlaps be-
tween independent publications and resultant confusion
as to which interactions are correct [17-19].
There are two major types of protein-protein inter-
action data – binary physical interactions and co-
complex associations. While some databases distinguish
between these two orthogonal datasets, others fail to do
so. Binary interactions represent a direct biophysical
interaction between two proteins. On the other hand,
co-complex associations provide information about co-
membership in a complex. A lot of these associations
may actually represent indirect interactions [17,18]. The
biological information conveyed by these two kinds oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Das and Yu BMC Systems Biology 2012, 6:92 Page 2 of 12
http://www.biomedcentral.com/1752-0509/6/92interactions is different and for many applications it is
necessary to have a clear distinction between these two.
There are two major methods to obtain a global map
of binary interactions – literature-curation (LC) and
high-throughput experiments (HT) [18]. LC refers to sys-
tematically collecting interaction data from thousands of
small-scale studies directed at validating a single or a few
specific hypotheses. On the other hand, HT experiments
produce large-scale interaction maps. Because most LC
data are generated by hypothesis-driven experiments, it
is much easier to infer biological function from those
studies as compared to HT experiments. On the other
hand, although the search space of some HT experiments
might be focused on certain functional groups, most HT
experiments are not designed to detect the presence or
absence of specific interactions. Any experiment can
have two kinds of bias – “assay bias” and “sampling bias”.
The first arises because no assay is perfect and all experi-
ments – HT or small-scale have their own characteristic
biases [20]. However, small-scale studies also have a sam-
pling bias, i.e., they are typically focused on one or a few
proteins of interest and hence selectively sample interac-
tions from only a part of the search space. HT experi-
ments are free of this sampling bias, i.e., the search space
is scanned without a priori expectations [17,19]. Thus,
for many global topological analyses, it is often necessary
to use only the HT datasets.
Here, we describe a publicly available protein-protein
interaction database, HINT (High-quality INTeractomes)
that directly addresses the above three issues and pro-
vides high-quality binary and co-complex interactions
for human, S. cerevisiae, S. pombe, and O. sativa. The
binary interactomes have also been divided into LC and
HT subsets. Using these datasets, we show that there
are significant sociological sampling biases in LC data-
sets, i.e., well-studied proteins tend to have more inter-
actions in LC datasets for both human and S. cerevisiae.
Finally, using only the high-quality HT interactions for
human, we find that disease genes (i.e., genes that have a
causal connection with one or more diseases) with more
interactions tend to cause more diseases. Even though
this result is unexpected in light of previous findings
that interaction hubs are less likely to cause disease
[21,22], it will help understand mechanisms of various
disease processes and develop corresponding treatments.
Results and Discussion
Data source for protein-protein interactions
The set of all protein-protein interactions for the organ-
isms was downloaded from the public databases – Bio-
Grid [9], DIP [10], HPRD [11], IntAct [12], iRefWeb [13],
MINT [14], MIPS [15] and VisAnt [16]. Not all four
organisms were present in all the databases. Though
some of the databases mentioned above store bothgenetic and physical interactions, only physical interac-
tions were used in building the interactomes. Certain
tools [13,23] also provide scoring schemes for protein-
protein interactions. However, we do not include these
for HINT as they integrate both computational predic-
tions and experimentally determined interactions. Our
goal is to provide a repository of only experimentally
well-validated high-quality protein-protein interactions.
Building the database
Figure 1 summarizes how HINT was built. For each or-
ganism and each source database, a filter was applied to
generate non-redundant lists of appropriate interactions
for the two categories – binary and co-complex. The fil-
ter classifies interactions into the correct groups and
removes ones that are inadequately supported by experi-
mental evidence. The binary interactions were further
classified as HT and LC based on the nature of the
experiments that produced them. If the experiment in
support of the interactions discovers greater than a cut-
off number of interactions, it is classified as HT. To de-
termine the cutoff, we calculated the distribution of
number of interactions reported by each unique publica-
tion. The cutoff (> = 100 interactions) corresponds to the
top 0.5 percentile of studies, when all publications are
ranked in decreasing order of interactions reported per
study (Additional file 1: Figure S1). For co-complex asso-
ciations, there exists no such clear distinction between
HT and LC because the average number of interactions
detected in a single experiment is significantly higher.
The next step was to remove low-quality interactions.
For ones supported by HT publications, a non-
redundant list of papers was compiled and each publica-
tion was manually examined to verify that the actual
experiments used by the authors agree with the evidence
codes cited by the curators. All papers for which there
was an error in this matching process were removed.
Moreover, papers that do not validate the interactions
obtained were also not included in HINT. Although
some HT affinity purification followed by mass spec-
trometry (AP/MS) experiments producing co-complex
associations report confidence scores, most binary HT
experiments do not. For co-complex interactions, we re-
quire all interactions to be reported by two papers or
more to ensure quality. For HT binary experiments,
some report datasets of different levels of confidence –
usually, core vs. non-core. We always include the
highest-quality dataset (i.e., the core set only). Moreover,
we ensure that every single interaction included is high-
quality (please see Quality control section). Within this
high-quality dataset, the users of HINT are free to
choose their own confidence cutoff based on any com-
bination of the number of supporting publications and
evidence code. For LC interactions, it is not possible to
Table 1 Source databases – download dates and versions
Database Download date (version if applicable)
BioGrid 11 January 2012 (v 3.1.84)
DIP 12 January 2012
HPRD 12 January 2012 (Release 9)
IntAct 12 January 2012 (2011 release)
iRefWeb 12 January 2012 (v 4.1)
MINT 17 January 2012 (2012 release)
MIPS 17 January 2012
VisAnt 13 January 2012 (Release 3.93)
Figure 1 Flow diagram depicting the series of steps used to
build HINT..
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high. It has been shown that a large fraction of the LC
interactions supported by a single publication cannot be
verified [18,24]. Curation is an extremely painstaking
process and we acknowledge that there may be some
high-quality interactions supported by only one publica-
tion. However, it is impossible to distinguish them from
the larger fraction that has been demonstrated to be of
lower quality/erroneous [17,19]. Our goal here is to
present to the community only a high-quality dataset
that is free of potential biases due to differential curation
of the same source publication. Only those LC interac-
tions that are supported by two or more publications are
preserved in our database. Table 1 provides a summary
of the source databases used (version and download
date). Table 2 reports the number of high-qualityinteractions in each of these databases in each category
(no high-quality co-complex associations were obtained
for O. sativa).
For the binary network, we generated two sub-
interactomes – the high-quality LC (HQ-LC) and the
high-quality HT (HQ-HT) sub-interactomes. Interactions
that are supported by both forms of evidence belong
to both.
Tables 3, 4 and 5 provides summary statistics for the
different interactomes and their sub-classes. The num-
bers refer to unique entries and any interaction validated
in multiple orientations (e.g., bait and prey in binary
interaction detection experiments) or by different re-
search groups is counted as a single entity. We find that
the average degree for both S. pombe and O. sativa are
much lower than that of human or S. cerevisiae for both
binary and co-complex data. This shows that the S.
pombe and O. sativa interactomes are still mostly unex-
plored. There is also a sharp increase in the average de-
gree from binary to co-complex for S. cerevisiae. This is
expected given that models to generate topologies of co-
complex networks tend to include several or all possible
combinations [25]. However, the same does not hold
true for human. This probably indicates that the human
co-complex interactome is underexplored as compared
to the S. cerevisiae one.
Figure 2 depicts the binary and co-complex interac-
tomes for human and S. cerevisiae. The degree distribu-
tion of each of the networks is also illustrated and these
plots correspond well with the theoretical expectation of
the networks being scale-free [26]. It is not possible to
produce these plots for S. pombe and O. sativa as the
interactomes for these organisms are severely underex-
plored. The S. pombe networks are available as Add-
itional file 2: Figure S2.
Quality control
There has been a great deal of effort in the literature at
discovering new protein-protein interactions in different
species to gain an understanding of the entire interactome
of that organism. However, due to experimental errors
Table 2 Database statistics – Summary of high-quality interactions obtained from the different data-sources and those
finally included in HINT
Database Human binary Human
co-complex
S. cerevisiae binary S. cerevisiae
co-complex
S. pombe binary S. pombe
co-complex
O. sativa binary
HINT 27356 7629 11936 16294 160 417 211
BioGrid 13244 6175 8458 13053 110 375 -
DIP 455 336 1905 1510 - -
HPRD 15449 - - - - - -
IntAct 10226 2438 4906 10539 72 201 1
iRefWeb 17216 5554 10005 14122 125 386 -
MINT 2379 740 1397 1603 - - -
MIPS - - 1624 274 - - -
VisAnt 13913 4882 7337 13632 69 264 210
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tions that are low quality/erroneous [18]. Since accuracy
is of paramount importance in generating new hypotheses
using these interaction data, it is essential to have an eas-
ily accessible repository of high-quality binary protein-
protein interactions. HINT is a repository created by
combining information from commonly used databases.
To ensure quality control, we adopt the following proto-
col. Since the number of HT publications is relatively low
as compared to the vast number of small-scale studies,
we manually inspect each of the HT studies (Additional
file 3: Table S1 and Additional file 4: Table S2). We ensure
that high-quality HT experiments included in HINT have
been verified by orthogonal traditional assays (e.g., co-
immunoprecipitation). Some experiments that do not
perform any validation of their screen are considered
low-quality and therefore removed. More recently, we
developed a statistical framework to comprehensively
evaluate the quality of HT datasets verified by orthogonal
assays in both human and S. cerevisiae [17,19]. Using this
framework, we can quantitatively and experimentally
measure the quality of individual interactions, as well as
the whole dataset. The quality of interactions reported by
a HT experiment can be measured by two independent
statistical parameters – the number of interactions vali-
dated, i.e., the “validation rate” and the number of interac-
tions that could be re-tested in the validation carried out,
i.e., the “retest rate”. The first parameter is a measure of






S. cerevisiae 18973 11936
S. pombe 1059 160
O. sativa 229 211(i.e., more confidence can be associated with the results
when a larger fraction of the reported interactions are
validated), while the second one directly assays the repro-
ducibility of the HT experiment. We carried out a com-
prehensive re-curation for all HT experiments included
in HINT. A list of these parameters for all the HT experi-
ments can be found in Additional file 5: Table S3 and
Additional file 6: Table S4.
On the other hand, since it is impossible to manually
check all small-scale studies, we require two independ-
ent publications to report the same interaction for it
to be included in our dataset. This is because while
some interactions from dedicated small-scale studies are
high-quality and have been repeated multiple times in
the literature, a significant fraction of interactions from
small-scale experiments are not easily reproducible. In
fact, many of the interactions that cannot be reproduced
are supported by only one publication, were not pro-
duced by dedicated experiments and were often not even
mentioned in the paper (Additional file 7: Figure S3)
[18]. More importantly, it has been experimentally
shown that such interactions are indeed of low quality
[17,19]. Thus, our repository of high-quality interactions
contains only manually validated HT experiments and
interactions from small-scale studies that have been
reported at least twice in the literature.
To further validate the filtering approach used we
adopted the following method. For each organism and

















Human 55452 7629 3189 4.785
S. cerevisiae 99343 16294 3380 9.641
S. pombe 3424 417 389 2.144
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were calculated before and after filtering. Since all these
databases are curating the same information, we would
expect the overlaps between any two of them to be high.
However, that is not the case and we find low overlaps
between pairs of databases. This supports our hypothesis
that some of the information contained in these datasets
is low-quality/incorrect. However, if our filtering scheme
successfully removes these low-quality/incorrect interac-
tions, the pairwise overlap between databases should
increase considerably after filtering. We find that this is
indeed the case. For each organism and interaction type,
there is a significant enrichment in the average pairwise
overlap between databases after filtering (Figure 3;
P-values calculated using a cumulative binomial test).
Specifically, let the maximum number of interactions for
a certain organism and interaction type that can be com-
mon to a particular database pair before and after filter-
ing be denoted by Mbi and Mai respectively, where i is
an index to denote the database pair. Let the percentage
overlaps before and after filtering for that pair be
denoted by Pbi and Pai respectively. The average per-
centage overlap for that organism and interaction type











The database has two major parts – a query interface
and a batch download for the entire interactomes of the






S. cerevisiae 9876 3624
Note: There are no high-quality HT experiments for S. pombe. Hence the whole
interactome is LC. There are no high-quality LC experiments for O. sativa.
Hence the whole interactome is HT.HINT. The pooled interactions can be queried in the
following manner.
The organism of interest is selected from a drop-down
menu followed by entering the query proteins separated
by semi-colons. Up to a maximum of 10 proteins can be
entered per query. The database supports Entrez gene
IDs [27] and gene names for proteins in human, ORF
names and gene names for proteins in S. cerevisiae [28]
and S. pombe [29] and Uniprot ids for O. sativa [30].
The user also has the option of specifying the cutoff
number of publications for each of the query proteins.
One can also specify a particular evidence type for
searching interactions. For each interacting protein, the
gene name is listed in the first column followed by the
list of Pubmed IDs of the papers supporting this inter-
action in column 2. The last column lists the PSI-MI
evidence code [31] that describes the kind of evidence
supporting the interaction. The gene names are linked
to the NCBI Entrez Gene database [27] for human and
S. cerevisiae, the GeneDB database [32] for S. pombe,
and the Uniprot database [30] for O. sativa. The
PubMed IDs link to the NCBI website for the relevant
abstracts.
For batch download, separate links are provided for
binary and co-complex interactomes for each organism.
The binary interactome is also divided into the LC and
HT networks. One notes here that the LC and HT net-
works are not completely mutually exclusive. There are
certain protein-protein interactions that have been dis-
covered both by HT experiments and by LC. There are
included in both interactomes.
Using HINT, it will now be possible to analyze,
visualize, and generate reliable hypotheses about a part
of or the complete interactome of the four different
organisms – human, S. cerevisiae, S. pombe, and O.
sativa. Future efforts may be directed at similarly col-
lecting and filtering data for other organisms and also
updating the current dataset based on new findings.
Binary vs co-complex
HINT clearly distinguishes between binary and co-
complex interactions. The binary network represents
direct interactions between two proteins. On the other
hand, the co-complex network merely indicates mem-
bership of a group and does not necessarily imply pair-
wise interactions. In most cases, the exactly topology of
Figure 2 Binary and co-complex interactomes and degree distribution plots for human and S. cerevisiae..
Das and Yu BMC Systems Biology 2012, 6:92 Page 6 of 12
http://www.biomedcentral.com/1752-0509/6/92the complex is unknown. Two primary methods – the
spoke model and the matrix model are used to represent
these complexes. However, both models are approxima-
tions and merely suggest possible topologies [25]. Since
different reports base their choice of model on study-
specific conditions, all co-complex associations were
included as curated in the source databases. No re-
curation was performed. Moreover, compared to co-
complex interactome models, binary maps have a greater
fraction of transient signaling connections and inter-
complex connections [17,33]. Since these two datasets
represent fundamentally different biological entities,
their overlap is low (Additional file 8: Figure S4) and it
is important to differentiate between them in certain
studies. For example, recent studies have examined how
mutations may either lead to complete loss of gene pro-
ducts or edge-specific changes in the interactome
[34,35]. We show in a recent study that the pathogenesis
of human disease can be better understood by looking at
the position of mutations on interaction interfaces [36].
These approaches are applicable to direct binaryinteractions, as it is more difficult to infer interface pairs
from co-complex associations. The latter can be resolved
using information on three-dimensional structures of
protein complexes if these are available. Thus, based on
the context, it may be more appropriate to use one
interactome over the other. Moreover, there are signifi-
cant differences in the topological properties of these
two networks. We calculated the clustering coefficient
[37] and the edge betweenness [38] for the different
interaction networks in HINT. Clustering coefficient
measures the density of clustering in an interaction net-
work [37]. We find that co-complex networks have a sig-
nificantly higher clustering coefficient (P < 10-8 in both
cases as calculated by a two-sample Kolmogorov-Smir-
nov test) than binary networks (Additional file 9: Figure
S5). This shows that co-complex associations tend to be
much more dense in terms of topological structure. Edge
betweenness is used to detect community structure in
networks. A higher betweenness value for an edge indi-
cates that it connects different modules and disrupting
this edge will fragment the network into disjoint
Figure 3 Average overlap percentage between all pairs of databases for binary and co-complex interactions in human, S. cerevisiae
(S.c.), and S. pombe (S.p.) before and after filtering..
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human and S. cerevisiae have a significantly higher
betweenness (P < 10-8 in both cases as calculated by a
two-sample Kolmogorov-Smirnov test) than co-complex
networks for the two organisms (Additional file 9: Figure
S5). This suggests that co-complex associations form
tightly regulated modules and binary interactions are
often used to form links between these modules. We did
not use the S. pombe or O. sativa networks for our glo-
bal topological calculations as these interactomes are
highly underexplored at this stage and the small number
of interactions available make the networks unsuitable
for global analyses.
HT protein-protein interactions in understanding human
disease
People have realized in the last decade that a human dis-
ease is rarely the consequence of an isolated abnormalityin a particular gene but is generally the outcome of com-
plex perturbations of the underlying cellular network
[39]. This has led to systematic studies of interactome
networks and numerous insights have been obtained
from such studies. The structure of these networks is
governed by key biological principles and changes in
their global properties may be linked to human disease
[40]. Further advances in such studies are expected to
uncover the biological significance of disease-associated
mutations discovered by genome-wide association stud-
ies [41] and help in identifying biomarkers and novel
drug targets [39].
Previous studies have shown that protein hubs tend to
be essential genes [42,43]. Therefore, one interesting
question is whether a lot of the hubs are disease genes.
Using the HT interactome, we examined the distribution
of disease genes across number of protein-protein inter-
actions. We found that disease-genes tend not to be
Figure 4 Screenshot of the user interface of HINT..
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of the mean assuming a binomial distribution). This
result is consistent with earlier studies that find that
disease genes are usually non-essential and occupy per-
ipheral positions in the human interactome [21,22]. The
finding is logical in light of an evolutionary argument –
for essential genes, mutations would be more likely to
affect fitness to the extent of causing embryonic lethality
[21,22].
However, we were unable to reproduce the same
results using the LC interactome (Figure 5A; error bars
correspond to standard error of the mean assuming a bi-
nomial distribution). There is a significant increase
(P < 10-8 as calculated by a one-way ANOVA) of percent-
age of disease genes with degree for proteins that have
at least one interaction. This led us to believe that the
difference could be due to study biases in the LC data.
To systematically analyze if this is true, we plotted the
average number of publications against the number of
interactions of proteins separately for the HT and LC
interactomes. Intuitively, there should be no strong cor-
relation between these two entities as the number of
publications associated with a protein should have no
connection with its degree. The average number ofpublications does not vary significantly with degree for
the HT dataset but increases dramatically for the LC
interactome (see Figures 5B and 5 C). This illustrates the
strong study bias in the LC data – proteins with a
greater number of interactions tend to be revisited more
often by small-scale studies. Our results are consistent
with earlier findings that the degree of proteins in the
LC interactome is strongly correlated with the number
of publications associated with them [17,44]. This makes
the LC interactome unsuitable for global topological
analyses. The low overlap between the HT and LC inter-
actomes (Additional file 8: Figure S4) also confirms that
these are in fact two separate networks that need to be
appropriately used based on the context.
To further investigate whether protein interactomes
can help us understand disease mechanisms and uncover
previously unknown disease genes, we used the HT
human interactome to analyze what fraction of disease
genes are disease-hubs, i.e., genes causing multiple dis-
eases. We examined the distribution of disease-hubs as a
function of their degrees (Figure 5D; error bars corres-
pond to standard error of the mean assuming a binomial
distribution). We observed that proteins with a higher
number of interactions are significantly more likely to be
A B
DC
Figure 5 A. Percentage of disease genes within proteins that have 0, 1, 2, 3, and>=4 interactions respectively. B. Plot of average
number of publications associated with a protein versus the cumulative degree of the protein in the HT and LC interaction networks in human.
C. Plot of average number of publications associated with a protein versus the cumulative degree of the protein in the HT and LC interaction
networks in S. cerevisiae. D. Percentage of disease hubs within disease genes that have 0,1, and>=2 interactions respectively.
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ANOVA). Though this may seem contradictory to earlier
findings in Figure 5A, these two are in fact independent
results. It is true that if a disease gene has more interac-
tions, there is a higher probability of its fitness being
affected. However, in Figure 5D, we focused only on dis-
ease genes. By virtue of the fact that these are observed
in the population as disease genes, their mutations are
less likely to cause embryonic lethality. Therefore the
evolutionary constrains in Figure 5A do not apply here.
It is logical to expect that a disease protein with multiple
interactions will have a greater propensity for causingmultiple diseases. This is because a protein with more
interactions is involved in more biological functions
[42]. This result also means that protein-protein interac-
tions are important in the pathogenesis of many human
diseases. Further studies on alteration of interactions by
disease mutations may reveal insights into molecular
mechanisms of various diseases and provide information
about potential drug targets.
Conclusions
HINT is a comprehensive repository of high-quality bin-
ary and co-complex physical interactions in human, S.
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implements systematic techniques for separating interac-
tions based on both type (i.e., binary and co-complex)
and data-source (i.e., LC and HT). Making these distinc-
tions is critical for many applications. Using only the HT
dataset, we demonstrated that human disease genes with
a greater number of interactions tend to cause more dis-
eases. Future directions involve implementation of the
same techniques for other organisms of biological
interest.
Methods
Evidence codes and ID-mapping
As one of the primary goals of the database is to clearly
distinguish binary interactions from co-complex associa-
tions, two separate and mutually exclusive lists of evi-
dence codes were created – one for each category. An
evidence code is a unique number assigned by the PSI-
MI initiative to a particular form of experimental infor-
mation in support of an interaction [31]. The lists used
for both categories can be found in Additional file 10:
Table S5, Additional file 11: Table S6 and Additional file
12: Table S7. Using these lists, all the interactions were
classified into binary and/or co-complex. Interactions
supported by evidence codes that are in neither of the
two lists are excluded. Different databases use different
gene identifiers and as this may lead to error, all gene
identifiers in each database were converted to Entrez
gene IDs for human, ORF names for S. cerevisiae and
S. pombe, and Uniprot ids for O. sativa. For each of
the organisms, gene names (when available) are also
provided in the bulk download files. Mapping files
we obtained from Uniprot [30] and the NCBI gene
databases.
As described earlier, for an interaction to qualify as
high-quality, it has to have at least one manually verified
HT evidence code or at least two LC evidence codes
supporting it. For certain database-specific details, please
refer to the Methods section in the Supplementary infor-
mation (Additional file 13: Supplementary Methods).
Protein-protein interactions and human disease genes
To look at the distribution of human disease genes
across number of protein-protein interactions, the fol-
lowing protocol was used. The total number of human
proteins is taken to be 20,000. For the LC and the HT
interactomes, we separately calculated the number of
proteins that take part in 1, 2, 3, and > =4 interactions
respectively. The difference of 20,000 and the sum of
proteins in all these categories represents the number of
proteins that have no known interactions in that particu-
lar network. Thus we have the number of proteins with
0, 1, 2, 3, and > =4 interactions for both interactomes.
The mapping between human genes and diseases isobtained from OMIM [45] and HGMD [46].Then the
following formula was used to calculate the percentage
of disease genes in each category (PGi):
PGi ¼ Ni x100Ti
where Ni is the number of disease genes in bin i and Ti
is the total number of genes in bin i.
Here each bin corresponds to the number of interac-
tions – 0, 1, 2, 3, and >=4 respectively. These values
have been shown in Figure 5A. The error bars represent
standard error of the mean assuming a binomial distri-
bution (each gene is either involved or not involved in
disease).
To calculate the sub-percentage of disease hubs in
each category (PHj), the following formula was used:
PHj ¼ Nj  100Tj
where Nj is the number of disease hubs in bin j and Tj is
the total number of disease genes in bin j.
Here each bin corresponds to the number of interac-
tions – 0, 1, and > =2 respectively and a disease hub is
any disease gene implicated in three or more diseases.
These values have been shown in Figure 5D. The error
bars represent standard error of the mean assuming a bi-
nomial distribution (each protein is either a disease hub
or it is not).
Additional files
Additional file 1: Histogram of number of interactions reported by
different studies focusing on detecting binary protein interactions
in human and S. cerevisiae respectively.
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